Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
CTV News
—
Moderna shares more than doubled after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind.
Merck, Moderna melanoma vaccine succeeds
- Merck, Moderna claim 'promising' skin cancer vaccine results in key trial IOL —
- Merck, Moderna Melanoma Vaccine Study Succeeds Bloomberg —
- Merck, Moderna claim encouraging melanoma vaccine trial results South China Morning Post —
- Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning The New York Times —
- Merck, Moderna Stocks Soar After Melanoma Trial Success 📹 Bloomberg — · 2min